<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01114100</url>
  </required_header>
  <id_info>
    <org_study_id>MEC99-128</org_study_id>
    <nct_id>NCT01114100</nct_id>
  </id_info>
  <brief_title>The Effects of Treatment With Sertraline for Noncardiac Chest Pain</brief_title>
  <official_title>The Effects of Treatment With Sertraline for Panic Disorder and/or Depression Driven Chest Pain and/or Palpitations in a Double Blind, Care as Usual and Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether care as usual or intervention (consisting
      of sertraline versus placebo), are effective in the treatment of panic disorder and/or
      depression driven noncardiac chest pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Noncardiac chest pain remains an important problem in clinical cardiology. Often, panic
      disorder and/or depression are the underlying cause. However, this is largely underdiagnosed.

      There are no clear existing treatment strategies/methods for this specific patient
      population.

      In our double blind, placebo controlled care as usual versus sertraline study, we want to
      investigate whether intervention is more effective as care as usual for diminishing chest
      pain, and also if sertraline is more effective in this specific population compared to
      placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Actual">December 2002</completion_date>
  <primary_completion_date type="Actual">December 2002</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>panic attacks</measure>
    <time_frame>24 weeks</time_frame>
    <description>reduction of panic attacks by more than or equal to 50%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>17 items Hamilton depression (HAMD) rating scale score</measure>
    <time_frame>24 weeks</time_frame>
    <description>reduction of HAMD score of &gt;50%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)reduction score</measure>
    <time_frame>24 weeks</time_frame>
    <description>reduction in Hospital Anxiety and Depression Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression (CGI) improvement</measure>
    <time_frame>24 weeks</time_frame>
    <description>improvement in Clinical Global Impression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol (EQ-5D)score</measure>
    <time_frame>24 weeks</time_frame>
    <description>improvement of Quality of Life measured by the EuroQol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) score</measure>
    <time_frame>24 weeks</time_frame>
    <description>improvement of Quality of Life measured by the SF 36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health care costs</measure>
    <time_frame>24 weeks</time_frame>
    <description>decrease of health care costs using a diary for health costs</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Panic Attacks</condition>
  <condition>Chest Pain</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>sertraline, panic education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treatment with sertraline after panic education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo after panic education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>treatment with placebo after panic education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>care as usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patient received no diagnosis an no panic education, they had a 24 weeks follow up with a visit at 12 weeks and 24 weeks to evaluate their complaints</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sertraline</intervention_name>
    <description>starting dose 25 mg for 1 week, the increasing to 50 mg, after each visit evaluation whether dosage has to be increased to maximally 150 mg</description>
    <arm_group_label>sertraline, panic education</arm_group_label>
    <other_name>sertraline, zoloft</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>patients received 1 pill, according to their complaints the number of pills was increased to maximally 3</description>
    <arm_group_label>placebo after panic education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chest pain without a cardiac cause

          -  diagnosed with panic disorder and or depression according to Diagnostic and
             statistical Manual (DSM) IV criteria

          -  Living &lt; 50 km from the hospital

          -  informed consent

        Exclusion Criteria:

          -  other primary DSM IV diagnosis

          -  known sensitivity to sertraline

          -  using other anti-depressive agents

          -  not speaking dutch language

          -  living in a nursery home or having dementia

          -  other severe, acute or progressive disease, kidney or liver-function disturbances,
             pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriaan Honig, Prof,MD,Phd</last_name>
    <role>Study Chair</role>
    <affiliation>Now: St Lucas and Andreas Hospital, Amsterdam, Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Petra Kuijpers, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Centre, Maastricht, the Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2010</study_first_submitted>
  <study_first_submitted_qc>April 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2010</study_first_posted>
  <last_update_submitted>May 17, 2010</last_update_submitted>
  <last_update_submitted_qc>May 17, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2010</last_update_posted>
  <responsible_party>
    <name_title>Pfizer</name_title>
    <organization>Prof dr A Honig</organization>
  </responsible_party>
  <keyword>chest pain</keyword>
  <keyword>panic attacks</keyword>
  <keyword>palpitations</keyword>
  <keyword>depression</keyword>
  <keyword>panic disorder</keyword>
  <keyword>depressive disorder</keyword>
  <keyword>non cardiac chest pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sertraline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

